Usana Health Sciences Inc.’s stock USNA, +1.59% fell 2% before turning flat in after-hours trade Tuesday, after the maker of nutritional supplements missed earnings estimates for the third quarter. Salt Lake City, Utah-based Usana posted net income of $11.3 million, or 59 cents a share, for the quarter, down from $14.9 million, or 78 cents a share, in the year-earlier period. Sales fell to $213.4 million from $233.3 million. The FactSet consensus was for EPS of 64 cents and revenue of $220.
“Operating results for the third quarter did not meet our expectations, largely because of challenging economic conditions across many of our regions and a lower cadence of promotional activity during the quarter,” CEO John Brown said in a statement. “These factors made it difficult to generate both Active Customer growth and top line momentum in our business.” The company lowered its full-year guidance and now expects EPS to range from $2.80 to $3.05, compared with prior guidance of $2.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »